What's breaking now, across thousands of outlets.
As dueling data emerge between their drug ivonescimab and a rival Merck medication, Summit and Akeso revealed new findings that impressed Wall Street.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
New diagnoses of cannabis use disorder (CUD) among adolescents in Northern California began climbing after recreational cannabis was legalized in California in 2016, reversing a steady decline in the…
A 40-year-old woman died on Saturday from complications associated with measles, the coroner reported.
CDC announces changes to how it reports measles deaths as Pennsylvania continues to confirm more cases The Trump administration has changed the way it counts measles deaths amid an outbreak in…
Affected animals include hippos, elephants, buffalo and a crocodile, all of which died after consuming the toxic, naturally occurring bacteria.
(MedPage Today) -- Abbott Laboratories will pay $385 million to resolve claims tied to an investigation of contamination at a baby formula factory in Sturgis, Michigan, the largest in the country…
(MedPage Today) -- The FDA approved aminolevulinic acid hydrochloride 10% (Ameluz) in combination with photodynamic therapy for treating adults with superficial basal cell carcinoma, maker Biofrontera…
